CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
New Androgen Receptor Axis-Targeted Agents in the Treatment of Nonmetastatic Castration-Resistant Prostate Cancer: From Bench to Clinical Trials
Jeong Hee Hong
Korean J Urol Oncol. 2020;18(2):99-108.   Published online 2020 August 27    DOI: https://doi.org/10.22465/kjuo.2020.18.2.99

Excel Download

New Androgen Receptor Axis-Targeted Agents in the Treatment of Nonmetastatic Castration-Resistant Prostate Cancer: From Bench to Clinical Trials
The Korean Journal of Urological Oncology. 2020;18(2):99-108   Crossref logo
Link1 Link2 Link3

Castration-Resistant Prostate Cancer Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents: Opportunities and Challenges
Cancers. 2018;10(10):345   Crossref logo
Link1

Second-generation Androgen Receptor–targeted Therapies in Nonmetastatic Castration-resistant Prostate Cancer: Effective Early Intervention or Intervening Too Early?
European Urology. 2016;70(6):971-973   Crossref logo
Link1 Link2

Red Cell Distribution Width Predicts Prostate-Specific Antigen Response and Survival of Patients With Castration-Resistant Prostate Cancer Treated With Androgen Receptor Axis–Targeted Agents
Clinical Genitourinary Cancer. 2019;17(3):223-230   Crossref logo
Link1 Link2

Androgen receptor targeted therapies in castration-resistant prostate cancer: Bench to clinic
International Journal of Urology. 2016;23(8):654-665   Crossref logo
Link1

Editorial Comment to Androgen receptor targeted therapies in castration-resistant prostate cancer: Bench to clinic
International Journal of Urology. 2016;23(8):666-666   Crossref logo
Link1

Chemotherapy and Androgen Receptor-Directed Treatment of Castration Resistant Metastatic Prostate Cancer
Management of Prostate Cancer. 2017;327-342   Crossref logo
Link1

Sequential Use of Androgen Receptor Axis-targeted Agents in Chemotherapy-naive Castration-resistant Prostate Cancer: A Multicenter Retrospective Analysis With 3-Year Follow-up
Clinical Genitourinary Cancer. 2020;18(1):e46-e54   Crossref logo
Link1 Link2

Comparative Assessment of Efficacies Between 2 Alternative Therapeutic Sequences With Novel Androgen Receptor-Axis-Targeted Agents in Patients With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer
Clinical Genitourinary Cancer. 2017;15(4):e591-e597   Crossref logo
Link1 Link2

Comparison of Sequential Treatment With Androgen Receptor-Targeted Agent Followed by Another Androgen Receptor-Targeted Agent Versus Androgen Receptor-Targeted Agent Followed by Docetaxel in Chemotherapy-Naive Patients With Metastatic Castration-Resistant Prostate Cancer
Clinical Genitourinary Cancer. 2017;15(6):e1073-e1080   Crossref logo
Link1 Link2